Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abivax S.A.

9.88
+1.0311.64%
Post-market: 10.190.3094+3.13%19:01 EDT
Volume:2.32M
Turnover:22.68M
Market Cap:627.10M
PE:-3.11
High:10.26
Open:10.02
Low:9.25
Close:8.85
Loading ...

Citizens JMP healthcare analysts hold an analyst/industry conference call

TIPRANKS
·
10 Jul

Guggenheim Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
21 Jun

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

MT Newswires Live
·
18 Jun

European Equities Traded in the US as American Depositary Receipts Slide Friday

MT Newswires Live
·
13 Jun

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

MT Newswires Live
·
11 Jun

European Equities Traded in the US as American Depositary Receipts Edge Higher Monday

MT Newswires Live
·
09 Jun

European Equities Traded in the US as American Depositary Receipts Advance Friday

MT Newswires Live
·
06 Jun

Abivax SA expected to post a loss of 73 cents a share - Earnings Preview

Reuters
·
30 May

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

GlobeNewswire
·
27 Mar

Abivax FY24 Net loss Stood At €(176.2)M Vs. €(147.8)M In FY23

Benzinga
·
24 Mar

Abivax Cash Position Stood At €144M As Of December 31, 2024

Benzinga
·
24 Mar

Abivax SA expected to post a loss of 68 cents a share - Earnings Preview

Reuters
·
21 Mar

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Piper Sandler

TIPRANKS
·
10 Mar

Piper Sandler Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
10 Feb

Morgan Stanley Sticks to Its Hold Rating for Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
28 Jan

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress

GlobeNewswire
·
24 Jan